Exozymes (EXOZ) Prepaid Assets (2023 - 2026)
Exozymes (EXOZ) posted quarterly Prepaid Assets of $382886.0 for Q4 2025, up 5.25% year-over-year from $363790.0 in Q4 2024, and up 87.03% quarter-over-quarter from $204720.0 in Q3 2025.
Exozymes (EXOZ) Prepaid Assets (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Prepaid Assets for 3 consecutive years, with $382886.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 5.25% year-over-year to $382886.0; the TTM figure through Dec 2025 stood at $382886.0 (up 5.25% YoY), while the FY2025 annual figure was $382886.0, up 5.25% from the prior year.
- Prepaid Assets improved to $382886.0 in Q4 2025 per EXOZ's latest filing, from $204720.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $634693.0 in Q3 2024 and bottomed at $204720.0 in Q3 2025.
- Historically, Prepaid Assets has averaged $350068.6 across 3 years, with a median of $312210.0 in 2025.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 37.4% — and 2025, when it slumped 67.75%.
- Exozymes' Prepaid Assets stood at $264762.0 in 2023, then surged by 37.4% to $363790.0 in 2024, then grew by 5.25% to $382886.0 in 2025.
- Business Quant data shows EXOZ's Prepaid Assets at $382886.0 in Q4 2025, $204720.0 in Q3 2025, and $287419.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exozymes | 62.35 Mn | 62.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 296,227.00 |
| Dec 31, 2025 | 382,886.00 |
| Sep 30, 2025 | 204,720.00 |
| Jun 30, 2025 | 287,419.00 |
| Mar 31, 2025 | 312,210.00 |
| Dec 31, 2024 | 363,790.00 |
| Sep 30, 2024 | 634,693.00 |
| Dec 31, 2023 | 264,762.00 |